Skip to main content

Albert Monserrat Companys

Albert Monserrat Companys

Albert Monserrat Companys

Albert Monserrat Companys

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Yassin Belahnech Pujol

Yassin Belahnech Pujol

Postdoctoral researcher
Cardiovascular Diseases
Read more
Marc Rivas Agudo

Marc Rivas Agudo

Research technician
Diabetes and Metabolism
Read more
Anna  Pascual  Carreño

Anna Pascual Carreño

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Meritxell Ventura Cots

Meritxell Ventura Cots

Main researcher
Liver Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.